All hypotheses on Covid-19 origins 'remain on the table': WHO chief
Live Events
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
All hypotheses on how the Covid-19 pandemic began remain on the table, the World Health Organization said Thursday following an inconclusive investigation into the global catastrophe's origins.The pandemic killed an estimated 20 million people, according to WHO, while shredding economies and crippling health systems.Understanding where the SARS-CoV-2 virus that causes Covid came from is seen as key to preventing future pandemics.The first cases were detected in Wuhan in China in late 2019, with the WHO first characterising the outbreak as a pandemic in March 2020.The WHO set up the Scientific Advisory Group for the Origins of Novel Pathogens ( SAGO ) to take the investigation into the pandemic's origins as far as they could.Its report was being published on Friday.WHO chief Tedros Adhanom Ghebreyesus said SAGO had advanced understanding of the origins of Covid-19 but much of the information needed to evaluate fully all the hypotheses had not been provided."Despite our repeated requests, China hasn't provided hundreds of viral sequences from individuals with Covid-19 early in the pandemic, more detailed information on animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan," he told a press conference."WHO is also aware of intelligence reports performed by other governments around the world on the origins of Covid-19. We have also requested access to those reports."As things stand, all hypotheses must remain on the table, including zoonotic spillover and lab leak."Tedros said the UN health agency continued to appeal to Beijing and other countries with information about the origins of Covid-19 to share the information openly, in the interests of protecting the world from future pandemics.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
35 minutes ago
- Economic Times
Alberta court halts ban on gender affirming care for youth as Premier vows to fight decision
Live Events Why this matters (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel A judge's decision last week to temporarily block Alberta 's new law banning gender-affirming care for youth under 16 has sparked a deep and emotional debate, one that centers not just on legal arguments, but on the real lives of vulnerable young Allison Kuntz granted the injunction, warning that halting access to puberty blockers and hormone therapy could inflict 'irreparable harm,' including forcing children through irreversible physical changes that don't align with their identity. 'The evidence shows that singling out health care for gender diverse youth will cause irreparable harm,' she wrote. Premier Danielle Smith countered forcefully during her radio show on June 28, stating, 'I feel there will be irreparable harm to children who get sterilized at the age of 10; we want those kids to have their day in court.' She emphasized the government's strategy as a precaution: preserving fertility until adulthood and cautioning against premature 'life-altering decisions.' The Premier described her approach as 'solid, measured, evidence-based—and on the side of kids.' Behind the courtroom rhetoric are dozens of health-care professionals and families urging Alberta to reconsider. Doctors explain that puberty blockers, used since the 1980s, even for cisgender children, are reversible and often life-saving. Studies show they reduce long-term mental health risks when started at ages 14– youth advocacy groups agree. Bennett Jensen of Egale Canada, which helped initiate the court challenge alongside the Skipping Stone Foundation, said the injunction provides 'huge relief' for the five youth (ages 6–11) named in the case. NDP Leader Naheed Nenshi celebrated the court's decision as 'a great day for young Albertans who simply want to live authentically and safely,' calling the law 'demonizing vulnerable kids'.Federal Health Minister Mark Holland called the policy 'deeply disturbing,' warning it risks children's safety and urged dialogue with Alberta's government . Alberta's legislation, first introduced in late 2024, was part of a larger package also affecting school pronouns and trans inclusion in sports. It passed the legislature in December but awaited full legal battle now moves upward. The court injunction offers temporary protection, but the core question of whether provincial governments can bar access to gender-affirming care without violating the Charter of Rights will be decided by a higher court.
Time of India
7 hours ago
- Time of India
Belapur to get 500-bed super specialty hosp post CRZ nod
Navi Mumbai: The state govt approved construction of a 500-bed super-specialty hospital in Belapur to be built in phases. The Navi Mumbai Municipal Corporation (NMMC) received directives to commence this significant project, which aims to enhance public healthcare services in Navi Mumbai. NMMC Commissioner Kailas Shinde confirmed obtaining essential permissions, including environment clearance and new development plan approval. The initial phase involves creating a 100-bed facility at a cost of Rs 250 crore. A previous tender process was suspended due to a High Court PIL regarding environment clearance and development plan approval issues. With current govt authorisation, NMMC plans to present the acquired permissions to the court to proceed with the public hospital construction. "The tender validity was extended and opening of the bidding will commence shortly. The govt urged swift construction initiation for public benefit," Shinde stated. "The comprehensive project, valued at Rs 800 crore, encompasses a medical college and super-specialty hospital with 500 beds. Phase one involves establishing a 100-bed super-specialty hospital at Rs 250 crore. Phase two, budgeted at Rs 550 crore, includes medical college construction and hospital expansion from 100 to 500 beds," explained Belapur MLA Manda Mhatre, who communicated with the chief minister for approval. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai The project faced challenges with partial land falling under the Coastal Regulation Zone (CRZ), requiring clearance. Additionally, NMMC's new draft Development Plan (DP) awaited state approval. "We secured both DP approval and CRZ clearance, clearing construction obstacles," confirmed Shinde. A civic official noted that while the plot was previously designated as a playground in the old DP, NMMC's new DP redesignated it for healthcare facilities. Phase one completion is estimated at 3-4 years. Cidco allocated approximately 32,000 square metres at plot 4, sector 15A, adjacent to civic headquarters in Belapur, for the medical college and super-specialty hospital. NMMC paid Rs 88 crore to Cidco for the land. "The development will utilise 22,000 square metres beyond CRZ restrictions, with approval secured. The remaining 10,000 square metres under CRZ remains non-developable," NMMC clarified. "The pandemic highlighted the necessity for public healthcare facilities when Covid patients struggled to access affordable treatment and specialist care," Mhatre noted. Cidco sources indicate the plot's designation in NMMC's draft DP as a park could be modified for healthcare purposes. However, local residents who use the space as a recreational area expressed opposition.
Time of India
8 hours ago
- Time of India
Zero-dose children in India declined from 0.11% in 2023 to 0.06% in 2024: Union Health Ministry
New Delhi: The percentage of zero-dose children (Those who have not received a single vaccine ) in India has declined from 0.11% in 2023 to 0.06% in 2024, according to the Union Ministry of Health and Family Welfare. The ministry attributed the achievement to continued and sustained efforts and intensified implementation of vaccination drives and campaigns across the country. These achievements have positioned India as a global exemplar in child health, as acknowledged by the UN Inter-agency Group for Child Mortality Estimation (UN IGME) in its 2024 report. India has been bestowed with the prestigious Measles and Rubella Champion Award by The Measles and Rubella Partnership (American Red Cross, BMGF, GAVI, US CDC, UNF, UNICEF, and WHO) at the American Red Cross Headquarters in Washington, DC, USA on March 6th, 2024, for its committed endeavours, said the ministry. The effect of the increased number of lifesaving vaccines in reducing mortality and morbidity in children due to diarrhea, pneumonia, meningitis & encephalitis is also clearly observable. As per the latest SRS (2020-22), the Maternal Mortality Ratio (MMR) of India has declined from 130/lakh live births in 2014-16 to 88/lakh live births in 2020-22. As per the United Nations Maternal Mortality Estimation Inter-Agency Group (UN-MMEIG 2000-2023) report, the MMR of India stands at 80 per lakh live births, reflecting an 86% decline relative to the global reduction of 48% since 1990. As per the United Nations Inter-Agency Group for Child Mortality Estimation (UNIGME 2024 Report), India achieved a 78% decline in the Under-Five Mortality Rate (U5MR) surpassing the global reduction of 61% and 70% decline in the Neonatal Mortality Rate (NMR) compared to 54% globally during 1990 - 2023. In addition to focused attention on increasing vaccination coverage, India's Universal Immunisation Programme (UIP) embodies a comprehensive range of vaccines recommended by the World Health Organisation (WHO). Till 2013, there were only six available vaccines in the program. From 2014, six new vaccines (namely Inactivated Polio-virus Vaccine, Rotavirus Vaccine (RVV), Pneumococcal Conjugate Vaccine (PCV), Measles-Rubella Vaccine, Adult Japanese Encephalitis Vaccine and Tetanus-Diphtheria Vaccine) have been introduced in the programme. Currently, India's UIP covers 12 vaccine-preventable diseases and has seen significant expansion. With continued focus on improving vaccine coverage, India has taken a proactive and inclusive approach to reach underserved populations. The Govt of India, in consultation with all States/UTs, has launched targeted campaigns to address challenges among zero-dose children, particularly in urban slums, peri-urban areas, migratory populations, hard-to-reach regions, and communities affected by vaccine hesitancy. These efforts are also aligned with the National goal of eliminating Measles and Rubella. "To amplify our reach, we are leveraging technology and community engagement. The U-WIN platform tracks immunisation status digitally, ensuring no child is missed. Public awareness campaigns are being intensified using mass media, community radio, social media, and even street plays to educate families. Healthcare workers, ASHAs, and ANMs will go door-to-door, not just to vaccinate, but to sensitise the beneficiaries about the benefits of vaccination," the ministry said in a press release. Some key initiatives include: Zero Dose Implementation Plan 2024: Rolled out across 143 districts in 11 states with a high burden of unvaccinated children. Mission Indradhanush (Since 2014): Intensified in 2017 in collaboration with state governments, it has vaccinated 5.46 crore children and 1.32 crore pregnant women previously unreached or under-vaccinated. Pulse Polio Campaigns: Through National Immunization Days (NIDs) and Sub-National Immunization Days (SNIDs), India has maintained polio-free status since 2014. Village Health and Nutrition Days (VHNDs): Organized regularly for immunization and outreach activities at the community level. Multi-tiered Task Forces: State (STFI), District (DTFI), and Block (BTFI) level task forces ensure coordinated and effective implementation. Regular IEC (Information, Education, Communication) Campaigns: Help increase awareness and combat vaccine hesitancy. The annual birth cohort in India (2.6 crore) exceeds the total population of several countries, including New Zealand, Australia, Finland, and Switzerland. Given the varying sizes of the countries across the globe, the percentage comparison shows it at par with the vaccination coverage levels observed in many high-income countries for e.g., New Zealand (DTP-1 93%), Germany & Finland (DPT-3 91%), Sweden (MCV-1 93%), Luxembourg (MCV-2 90%), Ireland (PCV-3 83%), United Kingdom of Great Britain and Northern Ireland (Rota C 90%). ( WUNEIC report 2023). The comparative results of countries on zero dose children as a percentage of the total population shows that Yemen (1.68%), Sudan (1.45%), Angola (1.1%), Afghanistan (1.1%), Nigeria (0.98%), DR Congo (0.82%), Ethiopia (0.72%), Indonesia (0.23%), Pakistan (0.16%) have far more zero dose children as a percentage of their population compared to India's (0.11% during 2023 as per the last Wuneic report released. Any comparison of India with any other countries with high burden zero-dose children needs to take into consideration India's large population size and high vaccination coverage rate. Therefore, any interpretation or analysis based on isolated factors does not lend credence to the country's progress on its immunisation program, said the ministry. The Universal immunisation program has always been prioritised by the Government of India to ensure that the children of our country are protected against deadly diseases. Elimination of Polio in 2014 and Maternal & Neonatal Tetanus in 2015, and the recent launch of the Measles Rubella campaign in 2025 is a testament to the fact. With focused strategies and committed healthcare workers, the endeavour will always be last-mile delivery to ensure comprehensive vaccination coverage. Vaccination remains one of the most powerful and cost-effective public health interventions. India's unwavering commitment to immunization is evident through its Universal Immunization Programme (UIP), which provides free vaccination services annually to 2.9 crore pregnant women and 2.6 crore infants (0-1 year).
